Global and United States Animal Vaccines Market Report & Forecast 2022-2028

Global and United States Animal Vaccines Market Report & Forecast 2022-2028

Table of Contents
1 Study Coverage
1.1 Animal Vaccines Product Introduction
1.2 Global Animal Vaccines Outlook 2017 VS 2022 VS 2028
1.2.1 Global Animal Vaccines Sales in US$ Million for the Year 2017-2028
1.2.2 Global Animal Vaccines Sales in Volume for the Year 2017-2028
1.3 United States Animal Vaccines Outlook 2017 VS 2022 VS 2028
1.3.1 United States Animal Vaccines Sales in US$ Million for the Year 2017-2028
1.3.2 United States Animal Vaccines Sales in Volume for the Year 2017-2028
1.4 Animal Vaccines Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Animal Vaccines in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Animal Vaccines Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Animal Vaccines Market Dynamics
1.5.1 Animal Vaccines Industry Trends
1.5.2 Animal Vaccines Market Drivers
1.5.3 Animal Vaccines Market Challenges
1.5.4 Animal Vaccines Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Animal Vaccines Market Segment by Type
2.1.1 Attenuated Vaccines
2.1.2 Inactivated Vaccines
2.1.3 Subunit Vaccines
2.1.4 Toxoid Vaccines
2.1.5 Conjugate Vaccines
2.1.6 Recombinant Vaccines
2.1.7 DNA Vaccines
2.2 Global Animal Vaccines Market Size by Type
2.2.1 Global Animal Vaccines Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Animal Vaccines Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Animal Vaccines Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Animal Vaccines Market Size by Type
2.3.1 United States Animal Vaccines Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Animal Vaccines Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Animal Vaccines Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Animal Vaccines Market Segment by Application
3.1.1 Companion Animals
3.1.2 Cattle
3.1.3 Pigs
3.1.4 Poultry
3.1.5 Sheep
3.2 Global Animal Vaccines Market Size by Application
3.2.1 Global Animal Vaccines Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Animal Vaccines Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Animal Vaccines Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Animal Vaccines Market Size by Application
3.3.1 United States Animal Vaccines Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Animal Vaccines Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Animal Vaccines Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Animal Vaccines Competitor Landscape by Company
4.1 Global Animal Vaccines Market Size by Company
4.1.1 Top Global Animal Vaccines Manufacturers Ranked by Revenue (2021)
4.1.2 Global Animal Vaccines Revenue by Manufacturer (2017-2022)
4.1.3 Global Animal Vaccines Sales by Manufacturer (2017-2022)
4.1.4 Global Animal Vaccines Price by Manufacturer (2017-2022)
4.2 Global Animal Vaccines Concentration Ratio (CR)
4.2.1 Animal Vaccines Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Animal Vaccines in 2021
4.2.3 Global Animal Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Animal Vaccines Manufacturing Base Distribution, Product Type
4.3.1 Global Animal Vaccines Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Animal Vaccines Product Type
4.3.3 Date of International Manufacturers Enter into Animal Vaccines Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Animal Vaccines Market Size by Company
4.5.1 Top Animal Vaccines Players in United States, Ranked by Revenue (2021)
4.5.2 United States Animal Vaccines Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Animal Vaccines Sales by Players (2020, 2021 & 2022)
5 Global Animal Vaccines Market Size by Region
5.1 Global Animal Vaccines Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Animal Vaccines Market Size in Volume by Region (2017-2028)
5.2.1 Global Animal Vaccines Sales in Volume by Region: 2017-2022
5.2.2 Global Animal Vaccines Sales in Volume Forecast by Region (2023-2028)
5.3 Global Animal Vaccines Market Size in Value by Region (2017-2028)
5.3.1 Global Animal Vaccines Sales in Value by Region: 2017-2022
5.3.2 Global Animal Vaccines Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Animal Vaccines Market Size YoY Growth 2017-2028
6.1.2 North America Animal Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Animal Vaccines Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Animal Vaccines Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Animal Vaccines Market Size YoY Growth 2017-2028
6.3.2 Europe Animal Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Animal Vaccines Market Size YoY Growth 2017-2028
6.4.2 Latin America Animal Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Animal Vaccines Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Animal Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Zoetis
7.1.1 Zoetis Corporation Information
7.1.2 Zoetis Description and Business Overview
7.1.3 Zoetis Animal Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Zoetis Animal Vaccines Products Offered
7.1.5 Zoetis Recent Development
7.2 Merck Animal Health
7.2.1 Merck Animal Health Corporation Information
7.2.2 Merck Animal Health Description and Business Overview
7.2.3 Merck Animal Health Animal Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Merck Animal Health Animal Vaccines Products Offered
7.2.5 Merck Animal Health Recent Development
7.3 Boehringer Ingelheim
7.3.1 Boehringer Ingelheim Corporation Information
7.3.2 Boehringer Ingelheim Description and Business Overview
7.3.3 Boehringer Ingelheim Animal Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Boehringer Ingelheim Animal Vaccines Products Offered
7.3.5 Boehringer Ingelheim Recent Development
7.4 Elanco
7.4.1 Elanco Corporation Information
7.4.2 Elanco Description and Business Overview
7.4.3 Elanco Animal Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Elanco Animal Vaccines Products Offered
7.4.5 Elanco Recent Development
7.5 Virbac
7.5.1 Virbac Corporation Information
7.5.2 Virbac Description and Business Overview
7.5.3 Virbac Animal Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Virbac Animal Vaccines Products Offered
7.5.5 Virbac Recent Development
7.6 Vetoquinol
7.6.1 Vetoquinol Corporation Information
7.6.2 Vetoquinol Description and Business Overview
7.6.3 Vetoquinol Animal Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Vetoquinol Animal Vaccines Products Offered
7.6.5 Vetoquinol Recent Development
7.7 Phibro Animal Health
7.7.1 Phibro Animal Health Corporation Information
7.7.2 Phibro Animal Health Description and Business Overview
7.7.3 Phibro Animal Health Animal Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Phibro Animal Health Animal Vaccines Products Offered
7.7.5 Phibro Animal Health Recent Development
7.8 Hester Biosciences
7.8.1 Hester Biosciences Corporation Information
7.8.2 Hester Biosciences Description and Business Overview
7.8.3 Hester Biosciences Animal Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Hester Biosciences Animal Vaccines Products Offered
7.8.5 Hester Biosciences Recent Development
7.9 Hipra
7.9.1 Hipra Corporation Information
7.9.2 Hipra Description and Business Overview
7.9.3 Hipra Animal Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Hipra Animal Vaccines Products Offered
7.9.5 Hipra Recent Development
7.10 IDT Biologika
7.10.1 IDT Biologika Corporation Information
7.10.2 IDT Biologika Description and Business Overview
7.10.3 IDT Biologika Animal Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.10.4 IDT Biologika Animal Vaccines Products Offered
7.10.5 IDT Biologika Recent Development
7.11 Biogenesis Bago
7.11.1 Biogenesis Bago Corporation Information
7.11.2 Biogenesis Bago Description and Business Overview
7.11.3 Biogenesis Bago Animal Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Biogenesis Bago Animal Vaccines Products Offered
7.11.5 Biogenesis Bago Recent Development
7.12 Tianjin Ringpu
7.12.1 Tianjin Ringpu Corporation Information
7.12.2 Tianjin Ringpu Description and Business Overview
7.12.3 Tianjin Ringpu Animal Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.12.4 Tianjin Ringpu Products Offered
7.12.5 Tianjin Ringpu Recent Development
7.13 China Animal Husbandry
7.13.1 China Animal Husbandry Corporation Information
7.13.2 China Animal Husbandry Description and Business Overview
7.13.3 China Animal Husbandry Animal Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.13.4 China Animal Husbandry Products Offered
7.13.5 China Animal Husbandry Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Animal Vaccines Industry Chain Analysis
8.2 Animal Vaccines Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Animal Vaccines Distributors
8.3 Animal Vaccines Production Mode & Process
8.4 Animal Vaccines Sales and Marketing
8.4.1 Animal Vaccines Sales Channels
8.4.2 Animal Vaccines Distributors
8.5 Animal Vaccines Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Animal Vaccines CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Animal Vaccines Market Trends
Table 3. Animal Vaccines Market Drivers
Table 4. Animal Vaccines Market Challenges
Table 5. Animal Vaccines Market Restraints
Table 6. Global Animal Vaccines Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Animal Vaccines Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Animal Vaccines Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Animal Vaccines Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Animal Vaccines Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Animal Vaccines Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Animal Vaccines Revenue Share by Manufacturer, 2017-2022
Table 13. Global Animal Vaccines Sales by Manufacturer, (K Units), 2017-2022
Table 14. Global Animal Vaccines Sales Share by Manufacturer, 2017-2022
Table 15. Global Animal Vaccines Price by Manufacturer (2017-2022) & (USD/Unit)
Table 16. Global Animal Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Animal Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Animal Vaccines as of 2021)
Table 18. Top Players of Animal Vaccines in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Animal Vaccines Product Type
Table 20. Date of International Manufacturers Enter into Animal Vaccines Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Animal Vaccines Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Animal Vaccines Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Animal Vaccines Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Animal Vaccines Sales by Players, (K Units), 2020, 2021 & 2022
Table 26. United States Animal Vaccines Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Animal Vaccines Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Animal Vaccines Sales in Volume by Region (2017-2022) & (K Units)
Table 29. Global Animal Vaccines Sales in Volume Forecast by Region (2023-2028) & (K Units)
Table 30. Global Animal Vaccines Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Animal Vaccines Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Animal Vaccines Sales in Volume by Country (2017-2028) & (K Units)
Table 33. North America Animal Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Animal Vaccines Sales in Volume by Region (2017-2028) & (K Units)
Table 35. Asia Pacific Animal Vaccines Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Animal Vaccines Sales in Volume by Country (2017-2028) & (K Units)
Table 37. Europe Animal Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Animal Vaccines Sales in Volume by Country (2017-2028) & (K Units)
Table 39. Latin Americaa Animal Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Animal Vaccines Sales in Volume by Country (2017-2028) & (K Units)
Table 41. Middle East and Africa Animal Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Zoetis Corporation Information
Table 43. Zoetis Description and Business Overview
Table 44. Zoetis Animal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 45. Zoetis Animal Vaccines Product
Table 46. Zoetis Recent Development
Table 47. Merck Animal Health Corporation Information
Table 48. Merck Animal Health Description and Business Overview
Table 49. Merck Animal Health Animal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 50. Merck Animal Health Product
Table 51. Merck Animal Health Recent Development
Table 52. Boehringer Ingelheim Corporation Information
Table 53. Boehringer Ingelheim Description and Business Overview
Table 54. Boehringer Ingelheim Animal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 55. Boehringer Ingelheim Product
Table 56. Boehringer Ingelheim Recent Development
Table 57. Elanco Corporation Information
Table 58. Elanco Description and Business Overview
Table 59. Elanco Animal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 60. Elanco Product
Table 61. Elanco Recent Development
Table 62. Virbac Corporation Information
Table 63. Virbac Description and Business Overview
Table 64. Virbac Animal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 65. Virbac Product
Table 66. Virbac Recent Development
Table 67. Vetoquinol Corporation Information
Table 68. Vetoquinol Description and Business Overview
Table 69. Vetoquinol Animal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 70. Vetoquinol Product
Table 71. Vetoquinol Recent Development
Table 72. Phibro Animal Health Corporation Information
Table 73. Phibro Animal Health Description and Business Overview
Table 74. Phibro Animal Health Animal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 75. Phibro Animal Health Product
Table 76. Phibro Animal Health Recent Development
Table 77. Hester Biosciences Corporation Information
Table 78. Hester Biosciences Description and Business Overview
Table 79. Hester Biosciences Animal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 80. Hester Biosciences Product
Table 81. Hester Biosciences Recent Development
Table 82. Hipra Corporation Information
Table 83. Hipra Description and Business Overview
Table 84. Hipra Animal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 85. Hipra Product
Table 86. Hipra Recent Development
Table 87. IDT Biologika Corporation Information
Table 88. IDT Biologika Description and Business Overview
Table 89. IDT Biologika Animal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 90. IDT Biologika Product
Table 91. IDT Biologika Recent Development
Table 92. Biogenesis Bago Corporation Information
Table 93. Biogenesis Bago Description and Business Overview
Table 94. Biogenesis Bago Animal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 95. Biogenesis Bago Product
Table 96. Biogenesis Bago Recent Development
Table 97. Tianjin Ringpu Corporation Information
Table 98. Tianjin Ringpu Description and Business Overview
Table 99. Tianjin Ringpu Animal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 100. Tianjin Ringpu Product
Table 101. Tianjin Ringpu Recent Development
Table 102. China Animal Husbandry Corporation Information
Table 103. China Animal Husbandry Description and Business Overview
Table 104. China Animal Husbandry Animal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 105. China Animal Husbandry Product
Table 106. China Animal Husbandry Recent Development
Table 107. Key Raw Materials Lists
Table 108. Raw Materials Key Suppliers Lists
Table 109. Animal Vaccines Customers List
Table 110. Animal Vaccines Distributors List
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Animal Vaccines Product Picture
Figure 2. Global Animal Vaccines Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Animal Vaccines Market Size 2017-2028 (US$ Million)
Figure 4. Global Animal Vaccines Sales 2017-2028 (K Units)
Figure 5. United States Animal Vaccines Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Animal Vaccines Market Size 2017-2028 (US$ Million)
Figure 7. United States Animal Vaccines Sales 2017-2028 (K Units)
Figure 8. United States Animal Vaccines Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Animal Vaccines Market Share in Global, in Volume (K Units) 2017-2028
Figure 10. Animal Vaccines Report Years Considered
Figure 11. Product Picture of Attenuated Vaccines
Figure 12. Product Picture of Inactivated Vaccines
Figure 13. Product Picture of Subunit Vaccines
Figure 14. Product Picture of Toxoid Vaccines
Figure 15. Product Picture of Conjugate Vaccines
Figure 16. Product Picture of Recombinant Vaccines
Figure 17. Product Picture of DNA Vaccines
Figure 18. Global Animal Vaccines Market Share by Type in 2022 & 2028
Figure 19. Global Animal Vaccines Sales in Value by Type (2017-2028) & (US$ Million)
Figure 20. Global Animal Vaccines Sales Market Share in Value by Type (2017-2028)
Figure 21. Global Animal Vaccines Sales by Type (2017-2028) & (K Units)
Figure 22. Global Animal Vaccines Sales Market Share in Volume by Type (2017-2028)
Figure 23. Global Animal Vaccines Price by Type (2017-2028) & (USD/Unit)
Figure 24. United States Animal Vaccines Market Share by Type in 2022 & 2028
Figure 25. United States Animal Vaccines Sales in Value by Type (2017-2028) & (US$ Million)
Figure 26. United States Animal Vaccines Sales Market Share in Value by Type (2017-2028)
Figure 27. United States Animal Vaccines Sales by Type (2017-2028) & (K Units)
Figure 28. United States Animal Vaccines Sales Market Share in Volume by Type (2017-2028)
Figure 29. United States Animal Vaccines Price by Type (2017-2028) & (USD/Unit)
Figure 30. Product Picture of Companion Animals
Figure 31. Product Picture of Cattle
Figure 32. Product Picture of Pigs
Figure 33. Product Picture of Poultry
Figure 34. Product Picture of Sheep
Figure 35. Global Animal Vaccines Market Share by Application in 2022 & 2028
Figure 36. Global Animal Vaccines Sales in Value by Application (2017-2028) & (US$ Million)
Figure 37. Global Animal Vaccines Sales Market Share in Value by Application (2017-2028)
Figure 38. Global Animal Vaccines Sales by Application (2017-2028) & (K Units)
Figure 39. Global Animal Vaccines Sales Market Share in Volume by Application (2017-2028)
Figure 40. Global Animal Vaccines Price by Application (2017-2028) & (USD/Unit)
Figure 41. United States Animal Vaccines Market Share by Application in 2022 & 2028
Figure 42. United States Animal Vaccines Sales in Value by Application (2017-2028) & (US$ Million)
Figure 43. United States Animal Vaccines Sales Market Share in Value by Application (2017-2028)
Figure 44. United States Animal Vaccines Sales by Application (2017-2028) & (K Units)
Figure 45. United States Animal Vaccines Sales Market Share in Volume by Application (2017-2028)
Figure 46. United States Animal Vaccines Price by Application (2017-2028) & (USD/Unit)
Figure 47. North America Animal Vaccines Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 48. North America Animal Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 49. U.S. Animal Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. Canada Animal Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Europe Animal Vaccines Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 52. Europe Animal Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 53. Germany Animal Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 54. France Animal Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. U.K. Animal Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. Italy Animal Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. Russia Animal Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. Asia-Pacific Animal Vaccines Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 59. Asia-Pacific Animal Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 60. China Animal Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Japan Animal Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. South Korea Animal Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. India Animal Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Australia Animal Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 65. Taiwan Animal Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 66. Indonesia Animal Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Thailand Animal Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Malaysia Animal Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 69. Philippines Animal Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 70. Latin America Animal Vaccines Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 71. Latin America Animal Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 72. Mexico Animal Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. Brazil Animal Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 74. Argentina Animal Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 75. Middle East & Africa Animal Vaccines Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 76. Middle East & Africa Animal Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 77. Turkey Animal Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 78. Saudi Arabia Animal Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 79. U.A.E Animal Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 80. Animal Vaccines Value Chain
Figure 81. Animal Vaccines Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs